0% found this document useful (0 votes)
14 views2 pages

Adipic Acid

The document outlines the specifications and testing methods for Adipic Acid, including its identification, assay procedures, and impurity limits. It specifies that Adipic Acid must contain between 98.0% and 102.0% of adipic acid on a dried basis, with strict criteria for impurities such as nitrates, chlorides, and sulfates. Additional requirements include packaging, storage, and reference standards for quality control.

Uploaded by

Ciprian
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
14 views2 pages

Adipic Acid

The document outlines the specifications and testing methods for Adipic Acid, including its identification, assay procedures, and impurity limits. It specifies that Adipic Acid must contain between 98.0% and 102.0% of adipic acid on a dried basis, with strict criteria for impurities such as nitrates, chlorides, and sulfates. Additional requirements include packaging, storage, and reference standards for quality control.

Uploaded by

Ciprian
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 2

Printed on: Thu Feb 09 2023, 12:00:11 AM(EST) Status: Currently Official on 09-Feb-2023 DocId: GUID-9B140FFF-9FC8-45B3-9BB6-CA5BA6E1EE5A_6_en-US

Printed by: Dang Van Vu Official Date: Official as of 01-Dec-2022 Document Type: NF @2023 USPC
Do Not Distribute DOI Ref: a9hsp DOI: https://doi.org/10.31003/USPNF_M724_06_01
1

CS = concentration of USP Adipic Acid RS in the


Adipic Acid Standard solution (mg/mL)
CU = concentration of Adipic Acid in the Sample
solution (mg/mL)

Acceptance criteria: 98.0%–102.0% on the dried basis


IMPURITIES
• RESIDUE ON IGNITION á281ñ: NMT 0.1%
• LIMIT OF NITRATES
Standard stock solution: 1.63 mg/mL of potassium nitrate
C6H10O4 146.14
Standard solution: Dilute 1 mL of the Standard stock
Hexanedioic acid; solution with water to 10 mL. Dilute 1 mL of this solution
1,4-Butanedicarboxylic acid CAS RN®: 124-04-9. with water to 50 mL to obtain a solution containing 2
DEFINITION µg/mL of nitrate.
Adipic Acid contains NLT 98.0% and NMT 102.0% of adipic Sample solution: Transfer 5 g of Adipic Acid to a 50-mL
acid (C6H10O4), calculated on the dried basis. volumetric flask. Dissolve in water, with heating, and dilute
with water to volume. Allow to cool and crystallize and then
IDENTIFICATION pass through a sintered-glass filter. Wash the filter with
• A. SPECTROSCOPIC IDENTIFICATION TESTS á197ñ, Infrared water, and collect the filtrate and washings until a volume
Spectroscopy: 197K of 50 mL is obtained. [NOTE—This solution is also to be
• B. The retention time of the adipic acid peak of the used for Chloride, Sulfate, and Iron.]
Sample solution corresponds to that of the Standard Control: 2 mg/L of potassium permanganate

al
solution, as obtained in the Assay. Analysis: Transfer 1.0 mL of the Sample solution, 1.5 mL of
ASSAY the Standard solution, and 1 mL of water (blank) to three
• PROCEDURE separate flasks. To each flask add 2 mL of ammonium
Solution A: 6.8 mL of 85% phosphoric acid in 4000 mL of hydroxide, 0.5 mL of 10 mg/mL manganese sulfate, and
water
ci 1 mL of 10 mg/mL sulfanilamide, and dilute each solution
Solution B: Acetonitrile with water to 20 mL. Add 100 mg of zinc powder to each
of the three flasks, and cool in an ice bath for 30 min,
Mobile phase: See Table 1.
shaking the solutions periodically. Separately filter 10 mL of
Table 1
each solution, cool in an ice bath, and then add 2.5 mL of
hydrochloric acid and 1 mL of 10 mg/mL of
Time Solution A Solution B naphthylethylenediamine dihydrochloride. Allow the
ffi
(min) (%) (%)
solutions to stand at room temperature for 15 min.
0.0 97 3 System suitability: The test is invalid if the concomitantly
5.0 97 3
prepared blank solution is darker than the Control.
Acceptance criteria: The color of the solution containing
20.0 45 55 the Sample solution is not darker than the concomitantly
O

20.1 97 3
prepared solution containing the Standard solution (NMT
30 ppm).
• CHLORIDE AND SULFATE á221ñ, Chloride
Re-equilibrate the column at the initial Mobile phase Sample: A 5-mL portion of the Sample solution from Limit of
composition before the next injection. Nitrates
Diluent: Acetonitrile and Solution A (3:97) Analysis: Proceed as directed in the chapter.
Standard solution: 0.5 mg/mL of USP Adipic Acid RS in Acceptance criteria: The Sample shows no more chloride
Diluent than a corresponding 0.14-mL portion of 0.020 N
Sample solution: 0.5 mg/mL of Adipic Acid in Diluent hydrochloric acid (NMT 0.02%).
Chromatographic system • CHLORIDE AND SULFATE á221ñ, Sulfate
(See Chromatography á621ñ, System Suitability.) Sample: A 5-mL portion of the Sample solution from Limit of
Mode: LC Nitrates
Detector: UV 209 nm Analysis: Proceed as directed in the chapter.
Column: 4.6-mm × 15-cm; 3-µm packing L1 Acceptance criteria: The Sample shows no more sulfate
Column temperature: 40° than a corresponding 0.26-mL portion of 0.020 N sulfuric
Flow rate: 1.0 mL/min acid (NMT 0.05%).
Injection volume: 30 µL • IRON á241ñ
System suitability Sample: A 10-mL portion of the Sample solution from Limit
Sample: Standard solution of Nitrates
Suitability requirements Analysis: Proceed as directed in the chapter.
Tailing factor: NMT 2.0 Acceptance criteria: NMT 10 ppm
Relative standard deviation: NMT 0.7%
Analysis Change to read:
Samples: Standard solution and Sample solution
Calculate the percentage of adipic acid (C6H10O4) in the • RELATED SUBSTANCES
portion of Adipic Acid taken: Solution A, Solution B, Mobile phase, Diluent, and
Chromatographic system: Proceed as directed in the
Result = (rU/rS) × (CS/CU) × 100 Assay.
Standard solution: 5 µg/mL of USP Adipic Acid RS
rU = peak area of adipic acid from the Sample solution Sample solution: 5 mg/mL of Adipic Acid in Diluent
rS = peak area of adipic acid from the Standard solution

https://online.uspnf.com/uspnf/document/1_GUID-9B140FFF-9FC8-45B3-9BB6-CA5BA6E1EE5A_6_en-US 1/2
www.webofpharma.com
Printed on: Thu Feb 09 2023, 12:00:11 AM(EST) Status: Currently Official on 09-Feb-2023 DocId: GUID-9B140FFF-9FC8-45B3-9BB6-CA5BA6E1EE5A_6_en-US
Printed by: Dang Van Vu Official Date: Official as of 01-Dec-2022 Document Type: NF @2023 USPC
Do Not Distribute DOI Ref: a9hsp DOI: https://doi.org/10.31003/USPNF_M724_06_01
2

System suitability Result = (rU/rS) × (CS/CU) × (1/FR) × FC × 100


Sample: Standard solution
[NOTE—See Table 2 for the relative retention times.] rU = peak area of each individual impurity from the
Sample solution
Table 2 rS = peak area of adipic acid from the Standard solution
Relative Relative CS = concentration of USP Adipic Acid RS in the
Retention Response Standard solution (µg/mL)
Compound Name Time Factor CU = concentration of Adipic Acid in the Sample
Maleic acid 0.31 140 solution (mg/mL)
FR = relative response factor from Table 2 for known
Succinic acid 0.35 0.88 impurities (use FR = 1 for unknown impurities)
Fumaric acid 0.39 179 FC = conversion factor, 0.001 mg/µg (µg to mg)
Glutaric acid 0.59 0.94
Acceptance criteria
Adipic acid 1.00 1.00 Individual impurity: NMT 0.1%
Total impurities: NMT 0.5%
Pimelic acid 1.21 0.91

Valeric acid ▲
1.46 0.88▲ (ERR 1-Dec-2022)
SPECIFIC TESTS
• MELTING RANGE OR TEMPERATURE á741ñ: 151°–154°
Hexanoic acid 1.77 0.59 • LOSS ON DRYING á731ñ: Dry a sample at 105° for 3 h; it loses
NMT 0.2% of its weight.
Suitability requirements ADDITIONAL REQUIREMENTS
Tailing factor: NMT 2.0

al
• PACKAGING AND STORAGE: Preserve in a tight container. No
Relative standard deviation: NMT 5.0% storage requirements are specified.
Analysis • USP REFERENCE STANDARDS á11ñ
Samples: Standard solution and Sample solution USP Adipic Acid RS
Calculate the percentage of each individual impurity,
excluding any solvent peaks, in the portion of Adipic Acid
taken:
ci
ffi
O

https://online.uspnf.com/uspnf/document/1_GUID-9B140FFF-9FC8-45B3-9BB6-CA5BA6E1EE5A_6_en-US 2/2
www.webofpharma.com

You might also like